AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

Extended letrozole improves disease-free survival in hormone receptor-positive breast cancer: 15-year results

Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer

Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer

UEG 2026: Improving early detection of colorectal cancer

Tarlatamab's role in SCLC

WCLC 2026: Lung cancer research highlights

Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati

Equitable precision oncology in Africa

Harnessing AI and data to predict, personalise and transform cancer care

Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC

Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia